Table 3. Univariate Comparison of Clinical and Histological Features Between the Two Groups of NAFLD or CHB Patients Divided by Degree of Fibrosis.
NAFLD | CHB | |||||
---|---|---|---|---|---|---|
Mild fibrosis | Advanced fibrosis | P value | Mild fibrosis | Advanced fibrosis | P value | |
Number | 40 | 12 | 35 | 33 | ||
Age | 40 | 59.0 | 0.002 | 37 | 41 | 0.390 |
Gender (Female) | 12 (30.0%) | 9 (75.0%) | 0.006 | 11 (31.4%) | 11 (33.3%) | 0.868 |
BMI (kg/m2) | 27.7 | 28.0 | 0.983 | 21.8 | 23.8 | 0.052 |
Obesity (BMI > 25) | 29 (72.5%) | 10 (83.3%) | 0.452 | 8 (22.9%) | 13 (39.4%) | 0.143 |
Diabetes | 16 (40.0%) | 8 (66.7%) | 0.108 | 2 (5.7) | 3 (9.1%) | 0.597 |
Hyperlipidemia | 28 (70.0%) | 7 (58.3%) | 0.454 | 12 (34.3%) | 10 (30.3%) | 0.728 |
Hypertension | 24 (60.0%) | 8 (66.7%) | 0.680 | 10 (28.6%) | 12 (36.4%) | 0.496 |
AST (U/L) | 55 | 73.5 | 0.487 | 50 | 49 | 0.750 |
ALT (U/L) | 93 | 81.5 | 0.307 | 76 | 79 | 0.589 |
Total bilirubin (mg/dL) | 0.6 | 0.8 | 0.081 | 0.8 | 0.6 | 0.083 |
Albumin (g/dL) | 4.3 | 4.0 | 0.016 | 4 | 3.7 | 0.160 |
Triglycerides (mg/dL) | 156.5 | 128.0 | 0.400 | 82 | 105 | 0.393 |
Total cholesterol (mg/dL) | 209 | 193 | 0.196 | 169 | 178 | 0.599 |
Glucose (mg/dL) | 96 | 111 | 0.424 | 85 | 92 | 0.233 |
Platelet count (104/µL) | 22.8 | 14.2 | < 0.001 | 18.5 | 15.2 | 0.004 |
Prothrombin time (%) | 100 | 77.5 | < 0.001 | 98.6 | 86 | 0.003 |
Appendectomy | 11 (27.5%) | 8 (66.7%) | 0.014 | 6 (17.1%) | 6 (18.2%) | 0.911 |
Steatosis (grade 0/1/2/3) | 0/11/17/12 | 0/6/6/0 | 0.036 | 21/7/6/1 | 16/14/3/0 | 0.717 |